Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE)

被引：0
|
作者：
Cindy T. McEvoy
Philip L. Ballard
Robert M. Ward
Joseph E. Rower
Rajan Wadhawan
Mark L. Hudak
Joern-Hendrik Weitkamp
Julia Harris
Jeanette Asselin
Cheryl Chapin
Roberta A. Ballard
机构：
[1] Oregon Health & Science University,Department of Pediatrics
[2] University of California San Francisco,Department of Pediatrics
[3] University of Utah,Department of Pediatrics
[4] University of Utah,Department of Pharmacology and Toxicology
[5] AdventHealth for Children,Department of Pediatrics
[6] University of Florida College of Medicine-Jacksonville,Department of Pediatrics
[7] Vanderbilt University Medical Center,Department of Pediatrics
[8] Oakland Children’s Hospital,Department of Pediatrics
来源：
Pediatric Research | 2020年 / 88卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：629 / 636
页数：7
相关论文
共 45 条
  • [31] Omeprazole vs famotidine for the prevention of gastroduodenal injury in high-risk users of low-dose aspirin: A randomized controlled trial
    Tseng, Zhi-Fu
    Hsu, Ping-, I
    Peng, Nan-Jing
    Kao, Sung-Shuo
    Tsay, Feng-Woei
    Cheng, Jin-Shiung
    Chen, Wen-Chi
    Tsai, Kun-Feng
    Tang, Sheng-Yeh
    Chuah, Seng-Kee
    Shie, Chang-Bih
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2021, 84 (01) : 19 - 24
  • [32] Combined treatment 3D-Conformal Radiotherapy plus HDR brachytherapy as treatment for intermediate or high-risk prostate cancer: Early toxicty and biochemical outcome of a dose-escalation prospective randomized trial
    Guix, B.
    Bartrina, J.
    Henriquez, I.
    Tello, J.
    Vendrell, J.
    Serrate, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S85 - S85
  • [33] Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates: Post HocAnalysis of a Randomized Clinical Trial (vol 174, pg 933, 2020)
    Heffler, Karen Frankel
    Bennett, David S.
    Subedi, Keshab
    JAMA PEDIATRICS, 2020, 174 (12) : 1224 - 1224
  • [34] Randomized Double-Blind 2 X 2 Trial of Low-Dose Tamoxifen and Fenretinide for Breast Cancer Prevention in High-Risk Premenopausal Women
    Decensi, Andrea
    Robertson, Chris
    Guerrieri-Gonzaga, Aliana
    Serrano, Davide
    Cazzaniga, Massimiliano
    Mora, Serena
    Gulisano, Marcella
    Johansson, Harriet
    Galimberti, Viviana
    Cassano, Enrico
    Moroni, Simona M.
    Formelli, Franca
    Lien, Ernst A.
    Pelosi, Giuseppe
    Johnson, Karen A.
    Bonanni, Bernardo
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (23) : 3749 - 3756
  • [35] RANDOMIZED CONTROLLED TRIAL OF LOW-DOSE WARFARIN IN THE PRIMARY PREVENTION OF ISCHEMIC HEART-DISEASE IN MEN AT HIGH-RISK - DESIGN AND PILOT-STUDY
    MEADE, TW
    WILKES, HC
    STIRLING, Y
    BRENNAN, PJ
    KELLEHER, C
    BROWNE, W
    EUROPEAN HEART JOURNAL, 1988, 9 (08) : 836 - 843
  • [36] A randomized double-blind 2x2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention of high-risk premenopausal women
    Decensi, A.
    Robertson, C.
    Guerrieri-Gonzaga, A.
    Serrano, D.
    Cazzaniga, M.
    Gulisano, M.
    Johansson, H.
    Cassano, E.
    Moroni, S.
    Johnson, K.
    Bonanni, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke prevention in atrial fibrillation III randomised clinical trial
    Blackshear, JL
    Baker, VS
    Rubino, F
    Safford, R
    Lane, G
    Flipse, T
    Malouf, J
    Thompson, R
    Webel, R
    Flaker, GC
    Young, L
    Hess, D
    Friedman, G
    Burger, R
    McAnulty, JH
    Coull, BM
    Marchant, C
    Timberg, J
    Janzik, C
    Giraud, G
    Halperin, B
    Kron, J
    Wynn, M
    Raitt, M
    Anderson, DC
    Asinger, RW
    Newburg, SM
    Fifield, J
    Bundlie, SR
    Koller, RL
    Tarrel, RD
    Dick, C
    Haugland, JM
    Jorgensen, CR
    Leonard, AD
    Kanter, MC
    Solomon, DH
    Zabalgoitia, M
    Mego, D
    Carter, JE
    Boyd, SY
    Boop, BS
    LaLonde, D
    Modlin, R
    Logan, WR
    Green, BJ
    Hamilton, WP
    Mezei, L
    Riggio, S
    Feldman, G
    LANCET, 1996, 348 (9028): : 633 - 638
  • [38] Dose escalation by high-dose 3D-conformal radiotherapy (HD-3D-CRT) or low-dose 3D-conformal radiotherapy plus HDR brachytherapy (LD-3D-CRT+HDR-B) for intermediate-or high-risk prostate cancer: Early results of a prospective comparative trial
    Guix, B.
    Bartrina, J.
    Tello, J.
    Quinzanos, L.
    Lacorte, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] Treatment of intermediate- or high-risk prostate cancer by dose escalation with high-dose 3D-conformal radiotherapy (HD-3D-CRT) or low-dose 3D-conformal radiotherapy plus HDR brachytherapy (LD-3D-CRT+HDR-B): Early results of a prospective comparative trial
    Guix, B.
    Bartrina, J.
    Tello, J.
    Quinzanos, L.
    Sole, J.
    Lacorte, T.
    Fernandez, J.
    Goix, I.
    Galdon, G.
    Espino, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] Treatment of Intermediate-or High-risk Prostate Cancer by Dose Escalation with High-dose 3D-conformal Radiotherapy (HD-3D-CRT) or Low-dose 3D-conformal Radiotherapy Plus HDR Brachytherapy (LD-3D-CRT+HDR-B): Early Results of a Prospective Comparative Trial
    Guix, B.
    Bartrina, J.
    Tello, J.
    Sole, J.
    Quinzanos, L.
    Lacorte, T.
    Fernandez, J.
    Leon, C.
    Guix, I.
    Galdon, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S78 - S78
12345